CNS Clinical Trials - Suicidality and Data Collection: Workshop Summary

"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future."--Publisher's description.

Dettagli sul prodotto

• Autori: Board On Health Sciences Policy, Forum on Neuroscience and Nervous System, Forum on Neuroscience and Nervous System Disorders, Institute Of Medicine
• Editore: National Academies Press
• Lingue: Inglese
• Formato: Tascabile
• Pubblicazione: 22.01.2011
• EAN: 9780309148832
• ISBN: 978-0-309-14883-2
• Pagine: 88
• Categoria: Scienze naturali, medicina, informatica, tecnica > Medicina > Branche non cliniche